O'Brart David P S
Keratoconus Research Institute, Department of Ophthalmology, St. Thomas Hospital, London, United Kingdom.
Clin Exp Optom. 2014 Jan;97(1):12-7. doi: 10.1111/cxo.12061. Epub 2013 May 8.
The aim was to review the recently published literature on excimer laser surface ablation procedures, including photorefractive keratectomy (PRK), laser sub-epithelial keratomileusis (LASEK), microkeratome-assisted PRK (epi-LASIK) and trans-epithelial (laser-assisted) PRK, to help elucidate where and how surface ablation may best fit into current refractive surgical practice. The emphasis was on publications within the last three years and included systemic reviews, meta-analyses and randomised controlled trials. Where such evidence did not exist, selective large series cohort studies, case-controlled studies and case series with follow-up preferably greater than six months were examined and included. Refractive and visual outcomes are excellent and comparable to those after LASIK even in complex cases after previous corneal surgery. Indeed, surface ablation combined with corneal collagen cross-linking may be used in selected eyes with biomechanical instability, where LASIK is contraindicated. In addition, there is evidence to suggest that there may be less induction of higher order aberrations with surface techniques. Long-term stability and safety appear to be extremely satisfactory. The literature supports the use of modern excimer laser surface treatments, with outcomes comparable to those after LASIK and evidence of less induction of higher-order aberrations. Follow-up studies at 10 to 20 years indicate excellent stability and safety.
目的是回顾最近发表的关于准分子激光表面消融手术的文献,包括准分子原位角膜磨镶术(PRK)、激光上皮下角膜磨镶术(LASEK)、微型角膜刀辅助PRK(上皮下准分子激光原位角膜磨镶术)和经上皮(激光辅助)PRK,以帮助阐明表面消融在当前屈光手术实践中最适合的应用场景及方式。重点是过去三年的出版物,包括系统评价、荟萃分析和随机对照试验。在缺乏此类证据的情况下,对选择性大样本队列研究、病例对照研究以及随访时间最好超过六个月的病例系列进行了审查并纳入。即使在既往角膜手术后的复杂病例中,屈光和视觉效果也非常好,与LASIK术后相当。实际上,表面消融联合角膜胶原交联可用于某些存在生物力学不稳定且LASIK为禁忌证的眼睛。此外,有证据表明表面技术可能较少诱导高阶像差。长期稳定性和安全性似乎非常令人满意。文献支持使用现代准分子激光表面治疗,其效果与LASIK术后相当,且有证据表明较少诱导高阶像差。10至20年的随访研究表明稳定性和安全性极佳。